High Protein Diet for Atherosclerosis
(HPA Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how different high-protein diets affect atherosclerosis, a condition that can lead to heart attacks and strokes. Researchers are testing meals with high animal protein, high plant protein, and plant protein with added leucine (an amino acid) to determine their influence on plaque buildup in arteries. Individuals who struggle with maintaining a healthy weight and have a BMI between 25.0 and 39.9 kg/m² might be a good fit for this trial.
As an unphased trial, this study offers a unique opportunity to contribute to understanding dietary impacts on heart health.
Will I have to stop taking my current medications?
The trial excludes participants who use medications or dietary supplements that could affect the study outcomes, so you may need to stop taking certain medications. It's best to discuss your specific medications with the trial coordinators.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that most people can handle a high-protein diet without problems. Studies have found that consuming more protein, whether from animals or plants, does not increase the risk of stroke or heart-related deaths. Some research even suggests that plant proteins might help lower blood pressure and reduce heart disease risks.
However, early animal studies suggested that a high-protein diet, especially with added leucine, might lead to plaque buildup in arteries, potentially raising the risk of heart issues. These effects have not been proven in humans.
In general, while a high-protein diet is usually safe, the type of protein consumed can affect heart health differently. Eating more plant-based proteins might benefit heart health more than animal proteins.12345Why are researchers excited about this trial?
Researchers are excited about these high-protein diet treatments for atherosclerosis because they offer a potential new way to combat this condition beyond standard medications like statins. Unlike typical treatments that focus on managing cholesterol levels through drugs, these diets emphasize increasing protein intake, specifically from plant and animal sources, which may influence heart health differently. The addition of leucine to one of the plant-based meal options could enhance muscle synthesis and overall cardiovascular benefits, setting these diets apart from conventional approaches. By exploring the impact of dietary protein on atherosclerosis, researchers hope to uncover alternative strategies that may complement or even reduce the need for medication.
What evidence suggests that this trial's treatments could be effective for atherosclerosis?
This trial will compare different dietary interventions: high plant protein meals, high animal protein meals, and standard meals. Research has shown that plant protein benefits heart health. Studies have found that replacing animal protein with plant protein can lower bad cholesterol levels. Plant protein is also linked to a reduced risk of heart disease and improved blood pressure. In contrast, animal protein might increase the risk of atherosclerosis, where plaque builds up in the arteries. Consuming large amounts of animal protein has been associated with a higher risk of heart problems. Another arm of this trial will test high plant protein meals with added leucine, an amino acid found in animal protein, which might reduce some heart health benefits of plant protein by contributing to plaque buildup.35678
Who Is on the Research Team?
Bettina Mittendorfer
Principal Investigator
University of Missouri-Columbia
Are You a Good Fit for This Trial?
This trial is for adults aged 45-75 with a BMI of 25.0 to less than 40.0 kg/m2, who do not smoke and have no significant organ dysfunction or allergies to meal ingredients. It excludes those on certain medications or supplements, highly active individuals, alcohol users with disorders, premenopausal women, prisoners, and anyone unable to consent.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive different dietary protein meals to study the impact on macrophage mTOR signaling and atherosclerosis
Follow-up
Participants are monitored for changes in monocyte p-S6 content and other cardiovascular markers
What Are the Treatments Tested in This Trial?
Interventions
- High Protein Diet
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Missouri-Columbia
Lead Sponsor
Washington University School of Medicine
Lead Sponsor